| Also known as |
BAY 12-8039 |
| Blood pressure |
No significant effects |
| Chemical name |
1-Cyclopropyl-7-[(S,S)-2,8-diazabicyclo[4.3.0]non-8-yl]-6-fluoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
| Dosage (medical) |
Typically 400 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Effective against a broad spectrum of gram-positive and gram-negative bacteria |
| Formula |
C21H24FN3O4 |
| Half-life |
Approximately 12 hours |
| Hepatotoxicity |
Rare, mild liver enzyme elevations |
| Lab Test |
Not specific |
| Main action |
Antibacterial |
| Raw Material |
Moksifloksasin |
| Side effects |
Nausea, diarrhea, dizziness, QT prolongation, tendon rupture |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Fluoroquinolone antibiotic |
| Trade name |
Avelox, Vigamox |
| Use in sports |
Not typically used in sports |
| Water Retention |
None |
| Manufacturer |
Bayer |
| Packing |
1 x 7 tabs (400 mg/tab) |
